| Patents for C07C 235 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms (15,664) |
|---|
| 01/21/2010 | WO2009145989A3 Aminoalkylphenyl antagonists of prostaglandin d2 receptors |
| 01/20/2010 | EP2145871A1 New method for preparing functionalised benzocyclobutenes and its application to the synthesis of ivabradine and its addition salts with a pharmaceutically acceptable acid. |
| 01/20/2010 | EP2144594A1 Alpha-galactosyl ceramide analogs and their use as immunotherapies |
| 01/20/2010 | EP1758853B1 Glucagon receptor antagonists, preparation and therapeutic uses |
| 01/20/2010 | EP1654247B1 Alkynyl aryl carboxamides |
| 01/20/2010 | CN100582092C Method for producing diphenyl azetidinone derivatives |
| 01/20/2010 | CN100582087C 2-aminobicyclo 3.1.0 hexane-2,6-dicarboxylic ester derivative |
| 01/19/2010 | US7649055 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support |
| 01/19/2010 | CA2351579C Enhanced catalyzed reporter deposition |
| 01/14/2010 | WO2010006085A1 Fatty acid acetylated salicylates and their uses |
| 01/14/2010 | WO2010003238A1 Phase 2 protein inducing alkamides |
| 01/14/2010 | WO2009109973A3 Compounds and methods of treating obesity |
| 01/14/2010 | CA2729186A1 Fatty acid acetylated salicylates and their uses |
| 01/13/2010 | EP2143709A1 Amide compound and use thereof |
| 01/13/2010 | EP1575911B1 Biaromatic compounds which activate ppar-gamma type receptors and use thereof in cosmetic or pharmaceutical compositions |
| 01/13/2010 | CN100579954C Method for producing (Z)-1-phenyl-1-diethylaminocarbonyl-2-hydroxymethylcyclopropane |
| 01/12/2010 | US7645791 5-tert-Butyl-4-hydroxy-2-methyl-biphenyl-3-carboxylic acid (2-chloro-4-nitro-phenyl) -amide; chemical uncouplers like for the treatment of obesity |
| 01/12/2010 | US7645780 N-[(1S,2R)-3-{[1-(3-bromophenyl)cyclopropyl]amino}-1-(3,5-difluorobenzyl)-2-hydroxypropyl]acetamide hydrochloride; for Alzheimer's disease; inhibitors of beta-secretase |
| 01/12/2010 | CA2511242C Inhibitors of human tumor-expressed ccxckr2 |
| 01/07/2010 | WO2010002625A1 Fluorinated esters |
| 01/07/2010 | WO2010000964A1 Microbiological method for synthesizing cinnamoyl amide derivatives of amino acids |
| 01/07/2010 | US20100003216 HCV NS-3 Serine Protease Inhibitors |
| 01/07/2010 | CA2724704A1 Fluorinated esters |
| 01/06/2010 | EP2139849A1 Process for making an acrylic monomer having one or more quaternary ammonium groups and its polymers |
| 01/06/2010 | CN100577642C Aluminium and copper metallized insulated material |
| 01/05/2010 | US7642290 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| 01/05/2010 | US7642289 Drugs for chronic pain |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090324540 Compounds and compositions for delivering active agents |
| 12/30/2009 | WO2009157196A1 Amide compound |
| 12/30/2009 | WO2009091506A3 Polyvinyl ultraviolet light absorbers for personal care |
| 12/30/2009 | EP1711481B1 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 12/30/2009 | CN101616890A Process for preparing entacapone substantially free of Z-isomer, synthesis intermediates thereof and a new crystalline form |
| 12/30/2009 | CN100575340C High-molecular cross-linked polymer and its preparation method |
| 12/30/2009 | CN100575330C Novel compounds |
| 12/29/2009 | US7638650 Fluoroalkyl surfactants |
| 12/29/2009 | US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors |
| 12/29/2009 | CA2477851C Small molecule entry inhibitors |
| 12/29/2009 | CA2370250C Di-aryl acid derivatives as ppar receptor ligands |
| 12/23/2009 | WO2009153206A2 Improved Process for the Production of Bimatoprost |
| 12/23/2009 | EP2135860A1 Improved process for the production of bimatoprost |
| 12/23/2009 | EP1796657B1 N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 12/23/2009 | CN101610995A Novel antagonists of the glucagon receptor |
| 12/23/2009 | CN101610764A Benzamide derivatives as EP4 receptor agonists |
| 12/23/2009 | CN100572356C Linking molecule for selective metallation of nucleic acid and its application |
| 12/22/2009 | US7635789 Fluoroalkyl acid amide surfactants |
| 12/22/2009 | CA2538095C Selective androgen receptor modulators and methods of use thereof |
| 12/22/2009 | CA2327465C Bipolar lipids capable of delivering polyanions to cells |
| 12/17/2009 | WO2009150119A1 Novel polymorphic forms of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid |
| 12/17/2009 | WO2009150118A2 Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid |
| 12/17/2009 | US20090312365 Certain Chemical Entities, Compositions, and Methods |
| 12/17/2009 | US20090311201 Lipoxin analogs and methods for the treatment of periodontal disease |
| 12/17/2009 | CA2727594A1 Novel polymorphic forms of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid |
| 12/17/2009 | CA2727587A1 Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid |
| 12/16/2009 | EP2133326A1 Novel pseudoglycolipid and use thereof |
| 12/16/2009 | EP2133325A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 12/16/2009 | CN101602940A Efficient dynamic hydrate inhibitor |
| 12/16/2009 | CN100569738C Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
| 12/15/2009 | US7632972 Compounds and methods for treatment of cancer and modulation of programmed cell death for melanoma and other cancer cells |
| 12/15/2009 | US7632970 Such as (R,R)-trans-1-[3,5-bis(trifluoromethyl)phenyl]-3-[2-(N,N-dimethylamino)cyclohexyl]thiourea |
| 12/10/2009 | WO2009147165A1 Novel ep4 receptor agonist compounds |
| 12/10/2009 | WO2009146539A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers |
| 12/10/2009 | WO2009109996A3 Novel cationic amphiphiles with quinic acid head-groups for dna vaccination |
| 12/10/2009 | US20090306214 Use of Syk Tyrosine Kinase Inhibitors for the Treatment of Cell Proliferative Disorders |
| 12/10/2009 | US20090306127 Certain Chemical Entities, Compositions and Methods |
| 12/10/2009 | CA2722723A1 4-(aminomethyl)cyclohexanamine derivatives as calcium channel blockers |
| 12/09/2009 | EP1409450B1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 12/09/2009 | CN101600683A Therapeutic compounds |
| 12/09/2009 | CN101597238A Preparation method of N, N-dimethyl-4-benzyloxy phenyl acetamide |
| 12/09/2009 | CN100567257C Functional monomers, process for preparing dispersants therewith, dispersants and lubricating oil compositions containing the dispersants |
| 12/09/2009 | CN100567242C Hsp90 family protein inhibitors |
| 12/08/2009 | US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 12/08/2009 | US7629367 Tissue-selective androgen receptor modulators (SARMs); male hypogonadism, prostate cancer, benign prostate hyperplasia, sarcopenia, rheumatoid arthritis and osteoarthritis; N-((5-cyclopropyl-2-fluoropyridin-3-yl)methyl)-2-phenylbutanamide for example |
| 12/08/2009 | CA2424396C Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
| 12/08/2009 | CA2422342C Novel amide derivatives and medicinal use thereof |
| 12/03/2009 | WO2009146067A2 Novel monomer for dental compositions |
| 12/03/2009 | WO2009145989A2 Aminoalkylphenyl antagonists of prostaglandin d2 receptors |
| 12/03/2009 | WO2009145816A2 Novel n-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents |
| 12/03/2009 | WO2009144197A1 Method for producing aromatic and heteroaromatic carboxylic acids, carboxylic acid esters and carboxylic acid amides |
| 12/03/2009 | WO2009110002A4 Novel efflux pump inhibitors |
| 12/03/2009 | WO2009075560A3 Process for the preparation of fluorinated acrylic derivatives |
| 12/03/2009 | US20090298947 Polymorphic and amorphous forms of lacosamide and amorphous compositions |
| 12/03/2009 | US20090298899 EP receptor (for which the endogenous ligand is prostaglandin E2, PGE2); {3-[(4-Chloro-biphenyl-3-carbonyl)-amino]-phenyl}-acetic acid; glaucoma or ocular hypertension; dysmenorrhoea, preterm labour, immune disorders, inflammatory disorders |
| 12/03/2009 | US20090298898 Pesticidally active ketone and oxime derivatives |
| 12/02/2009 | EP2128125A1 Caffeoyl quinic acid derivatives containing nitrogen, and preparation method, pharmaceutically composition and usage thereof |
| 12/02/2009 | CN100564344C 2- and 2,5-substituted phenylketo-enols |
| 12/01/2009 | US7625995 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 12/01/2009 | US7625948 Ester that inhibits MTP in intestines as antilipemic agents for side effect reduction |
| 12/01/2009 | CA2304362C Reagent and method for attaching target molecules to a surface |
| 11/26/2009 | WO2009115707A3 Preparation of hydroquinone amide compounds with antioxidant properties. |
| 11/26/2009 | US20090291998 Eponemycin and epoxomicin analogs and uses thereof |
| 11/26/2009 | US20090291988 Reversible Inhibitors of Monoamine Oxidase A and B |
| 11/25/2009 | EP2123630A1 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic ester derivative |
| 11/25/2009 | EP2121582A1 Process for preparing entacapone substantially free of z-isomer, synthesis intermediates thereof and a new crystalline form |
| 11/25/2009 | EP1638924B1 Pesticidally active ketone and oxime derivatives |
| 11/24/2009 | US7622612 Tricyclic derivatives and their use |
| 11/24/2009 | CA2443774C Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation |
| 11/24/2009 | CA2420962C Method for preparing crystal of 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]benzoic acid |
| 11/24/2009 | CA2418794C Calcium receptor antagonists |
| 11/24/2009 | CA2385882C Tyrosine derivatives |